Identification of key genes in prostate cancer gene expression profile by bioinformatics

被引:16
作者
Lu, Wenzong [1 ]
Ding, Zhe [1 ]
机构
[1] Xian Technol Univ, Coll Elect & Informat Engn, Dept Biomed Engn, Xian, Shaanxi, Peoples R China
关键词
bioinformatics; gene expression profile; prostate cancer; CELLS;
D O I
10.1111/and.13169
中图分类号
R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
摘要
The aim of this study was to identify key candidate genes in prostate cancer. The gene expression profiles of GSE32448, GSE45016, GSE46602 and GSE104749 were downloaded from the Gene Expression Omnibus database. The differentially expressed genes (DEGs) between prostate cancer and normal samples were identified by R language. The gene ontology functional and pathway enrichment analyses of DEGs were performed by the Database for Annotation, Visualization and Integrated Discovery software followed by the construction of protein-protein interaction network. Hub gene identification was performed by the plug-in cytoHubba in Cytoscape software. The 217 DEGs were significantly enriched in biological processes including epithelial cell differentiation, response to estradiol and several pathways, mainly associated with protein digestion and absorption pathway in prostate cancer. Epithelial cell adhesion molecule, twist family basic helix-loop-helix transcription factor 1, CD38 molecule and vascular endothelial growth factor A were identified as hub genes. The expression levels of hub genes were consistent with data obtained in The Cancer Genome Atlas for prostate adenocarcinoma. These hub genes may be used as potential targets for prostate cancer diagnosis and treatment.
引用
收藏
页数:10
相关论文
共 37 条
[1]  
[Anonymous], 2003, GENOME BIOL
[2]   Immunotherapies targeting CD38 in Multiple Myeloma [J].
Atanackovic, Djordje ;
Steinbach, Mary ;
Radhakrishnan, Sabarinath Venniyil ;
Luetkens, Tim .
ONCOIMMUNOLOGY, 2016, 5 (11)
[3]   Dysregulation of the vascular endothelial growth factor and semaphorin ligand-receptor families in prostate cancer metastasis [J].
Bender, R. Joseph ;
Mac Gabhann, Feilim .
BMC SYSTEMS BIOLOGY, 2015, 9
[4]   Estrogen receptor signaling in prostate cancer: Implications for carcinogenesis and tumor progression [J].
Bonkhoff, Helmut .
PROSTATE, 2018, 78 (01) :2-10
[5]   UALCAN: A Portal for Facilitating Tumor Subgroup Gene Expression and Survival Analyses [J].
Chandrashekar, Darshan S. ;
Bashel, Bhuwan ;
Balasubramanya, Sai Akshaya Hodigere ;
Creighton, Chad J. ;
Ponce-Rodriguez, Israel ;
Chakravarthi, Balabhadrapatruni V. S. K. ;
Varambally, Sooryanarayana .
NEOPLASIA, 2017, 19 (08) :649-658
[6]   MMP26: A potential biomarker for prostate cancer [J].
Cheng, Teng ;
Li, Fei ;
Wei, Rui ;
Lv, Meng-qin ;
Zhou, Yin ;
Dai, Yun ;
Yuan, Yuan ;
Jiang, Gui-ying ;
Ma, Ding ;
Gao, Qing-lei .
JOURNAL OF HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY-MEDICAL SCIENCES, 2017, 37 (06) :891-894
[7]   cytoHubba: identifying hub objects and sub-networks from complex interactome [J].
Chin, Chia-Hao ;
Chen, Shu-Hwa ;
Wu, Hsin-Hung ;
Ho, Chin-Wen ;
Ko, Ming-Tat ;
Lin, Chung-Yen .
BMC SYSTEMS BIOLOGY, 2014, 8
[8]   Safety and efficacy of abiraterone acetate in chemotherapy-naive patients with metastatic castration-resistant prostate cancer: an Italian multicenter "real life" study [J].
Cindolo, Luca ;
Natoli, Clara ;
De Nunzio, Cosimo ;
De Tursi, Michele ;
Valeriani, Maurizio ;
Giacinti, Silvana ;
Micali, Salvatore ;
Rizzo, Mino ;
Bianchi, Giampaolo ;
Martorana, Eugenio ;
Scarcia, Marcello ;
Ludovico, Giuseppe Mario ;
Bove, Pierluigi ;
Laudisi, Anastasia ;
Selvaggio, Oscar ;
Carrieri, Giuseppe ;
Bada, Maida ;
Castellan, Pietro ;
Boccasile, Stefano ;
Ditonno, Pasquale ;
Chiodini, Paolo ;
Verze, Paolo ;
Mirone, Vincenzo ;
Schips, Luigi .
BMC CANCER, 2017, 17
[9]   Adoptive T-cell therapy of prostate cancer targeting the cancer stem cell antigen EpCAM [J].
Deng, Zhenling ;
Wu, Yanhong ;
Ma, Wenbo ;
Zhang, Shuren ;
Zhang, Yu-Qian .
BMC IMMUNOLOGY, 2015, 16
[10]   Elevated osteonectin/SPARC expression in primary prostate cancer predicts metastatic progression [J].
DeRosa, C. A. ;
Furusato, B. ;
Shaheduzzaman, S. ;
Srikantan, V. ;
Wang, Z. ;
Chen, Y. ;
Siefert, M. ;
Ravindranath, L. ;
Young, D. ;
Nau, M. ;
Dobi, A. ;
Werner, T. ;
McLeod, D. G. ;
Vahey, M. T. ;
Sesterhenn, I. A. ;
Srivastava, S. ;
Petrovics, G. .
PROSTATE CANCER AND PROSTATIC DISEASES, 2012, 15 (02) :150-156